NOS3 and atherosclerosis: The oxidative degradation of BH4 as a mediator of eNOS uncoupling is best characterized as a “redox switch” in eNOS activity and supported by studies on hypertension, diabetes, hypercholesterolemia [72] and atherosclerosis [2,9,10,11,12,13].